share_log

JP Morgan Assumes Pacira BioSciences at Overweight, Announces Price Target of $45

Moomoo 24/7 ·  Mar 7 05:07

JP Morgan analyst Hardik Parikh assumes Pacira BioSciences (NASDAQ:PCRX) with a Overweight rating and announces Price Target of $45.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment